Cells + Products
IN VITRO
PROFILING
MARKET ORIENTED SCIENCE
HUMAN RESPONSE
OUR FUNCTION
Your decision making partner in humann
Immuno-staining
Flow cytometry
Fluorescence signals
Profiling
OUR SERVICES
PROFILeHIT AN INNOVATIVE PROFILING COMPANY
Cosmetical players – Food supplements producers
ProfileHIT is a French CRO exploring the pharmacological properties of new compounds, coming from natural products (algae, mushrooms, plants…), Medicinal Chemistry, Biotechnologies or from Agro-Food Industry.
Through an innovative approach, ProfileHIT brings an early access to the biological potential of new molecules. Based on its inedite detection-methods, ProfileHIT provides an early access to the potential benefit of a molecule, allowing a fast determination of its future uses or indications.
Furthermore, this screening-strategy enables the exclusion from the pipeline of some of the compounds which would present toxicities over the further testing-procedures, thus enabling the prevention of unnecessary investments for the companies.
ProfileHIT is a French CRO exploring the pharmacological properties of new compounds, coming from natural products (algae, mushrooms, plants…), Medicinal Chemistry, Biotechnologies or from Agro-Food Industry.
Through an innovative approach, ProfileHIT brings an early access to the biological potential of new molecules. Based on its inedite detection-methods, ProfileHIT provides an early access to the potential benefit of a molecule, allowing a fast determination of its future uses or indications.
Furthermore, this screening-strategy enables the exclusion from the pipeline of some of the compounds which would present toxicities over the further testing-procedures, thus enabling the prevention of unnecessary investments for the companies.
« Nous croyons en ce que la Science fait de mieux et nous faisons ce qu’il y a de mieux dans la Science : accélérer l’émergence de nouvelles thérapies »
Mathias CHATELAIS, ProfileHIT CEO.
The « Premium Drug Profiling » offers a fast answer for the Biotechnology companies and the Pharmaceutical Groups regarding the therapeutic response of their future drugs in Human.
ProfileHIT represents a unique opportunity for its customers to directly assess in vitro, the response of a drug candidate on the Human vascular peripheral system, before its first administration in Human.
As our screening-strategy can be done before the pre-clinical phases, it enables to exclude out of the pipeline some of the compounds which could present toxicities over the further testing-procedures.
Thus, this approach enables the prevention of unnecessary investments for the companies.
The « Premium Drug Profiling » offers a fast answer for the Biotechnology companies and the Pharmaceutical Groups regarding the therapeutic response of their future drugs in Human.
ProfileHIT represents a unique opportunity for its customers to directly assess in vitro, the response of a drug candidate on the Human vascular peripheral system, before its first administration in Human.
As our screening-strategy can be done before the pre-clinical phases, it enables to exclude out of the pipeline some of the compounds which could present toxicities over the further testing-procedures.
Thus, this approach enables the prevention of unnecessary investments for the companies.
Biotechnological and Pharmaceutical company
They trust us
